Health and Social Consequences of Injecting Drug Use

World Health Organization: Drug Injecting and HIV Infection: Global Dimensions and Local Responses

Volumn , Issue , 2003, Pages 42-57

  Donoghoe, Martin C ^a   Wodak, Alex ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85139611193     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203214015-9     Document Type: Chapter

References (54)

1. ALTER, H. (1996) ‘The cloning and clinical implications of HGV and HGBVC’, New England Journal of Medicine, 334, pp. 1536-7.
2. ANONYMOUS (1876) ‘Tetanus after hypodermic injection of morphia’, Lancet, 2, p. 873.
3. BARATA, L.C.B., ANDRAGUETTI, M.T.M. and DES MATOS, M.R. (1993) ‘Outbreak of malaria among injectable-drug users’, Revista de Saude Publica, 27, pp. 9-14.
4. BLUMBERG, B.S. (1990) ‘Sex-related aspects of hepatitis B and its consequences’, in PIOT, P. and ANDRE, F. (Eds) Hepatitis B: A Sexually Transmitted Disease in Heterosexuals, Oxford: Excerpta Medica.
5. BOUGHTON, C.R. and HAWKES, R.A. (1980) ‘Viral hepatitis and the drug cult: A brief socio-epidemiological study in Sydney’, Australia and New Zealand Journal of Medicine, 10, pp. 157-61.
6. CHERUBIN, C.E. and SAPIRA, J.O. (1993) ‘The medical complications of drug addiction and the medical assessment of the intravenous drug user twenty five years later’, Annals of Internal Medicine, 119, 10, pp. 1017-28.
7. CLEE, W.B. and HUNTER, P.R. (1987) ‘Hepatitis B in general practice:Epidemiology, clinical and serological features and control’, British Medical Journal, 295, pp. 530-2.
8. CROFTS, N., HOPPER, J.L., BOWDEN, D.S., BRESCHKIN, A.M., MILNER, R. and LOCARNINI, S.A. (1993) ‘Hepatitis C virus infection among a corhort of Victorian injecting drug users’, Medical Journal of Australia, 159, pp. 237-41.
9. DES JARLAIS, D.C., STIMSON, G.V., HAGAN, H., PERLMAN, D., CHOOPANYA, K., BAASTOS, F.I. and FRIEDMAN, S. (1996) ‘Emerging HIV infectious diseases and the injection of illicit psychoactive drugs’, Current Issues in Public Health, 2, pp. 130-7.
10. DIXON, L., HAAS, G., WEDIEN, P.J., SWEENEY, J. and FRANCES, A.J. (1991) ‘Drug abuse in schizophrenic patients: Clinical correlates and reasons for use’, American Journal of Psychiatry, 148, pp. 224-30.
11. DONOGHOE, M.C. (1992) ‘Sex, HIV and the injecting drug user’, British Journal of Addiction, 87, pp. 405-16.
12. DONOGHOE, M.C., RHODES, T.J., HUNTER, G.M. and STIMSON, G.V. (1993) ‘HIV testing and unreported HIV positivity among injecting drug users in London’, AIDS, 7, pp. 1105-11.
13. EDWARDS, G., ANDERSON, P., BARBOR, T.F.et al. (1994) Alcohol Polity and the Public Good, Oxford: Oxford University Press.
14. ENGLISH, D.R., HOLMAN, C.D.J., MILNE, E.et al. (1995) The Quantification of Drug Caused Morbidity and Mortality in Australia, Canberra:Commonwealth Department of Human Services and Health.
15. ENGSTROM, A., ADAMSSON, C., ALLEBECK, P. and RYDBERG, U. (1991) ‘Mortality in patients with substance abuse: A follow-up in Stockholm County, 1973-1984', International Journal of Addiction, 26, pp. 91-106.
16. FRIEDMAN, S.R., DES JARLAIS, D.C., WARD, T.P., JOSE, B., NEAIGUS, A., GOLDSTEIN, M.F. (1993) ‘Drug injectors and heterosexual AIDS’, in SHERR, L. (Ed.) AIDS and the Heterosexual Population, London: Harwood Academic Publishers.
17. FRISCHER, M., GREEN, S.T. and GOLDBERG, D. (1994) Substance Abuse Related Mortality: A Worldwide Review, Austria: United Nations International Drug Control Programme.
18. GERADA, C., ORGEL, M. and STRANG, J. (1992) ‘Health clinics for problem drug misusers’, Health Trends, 24, pp. 68-9.
19. GRAY, J. (1995) ‘Operating syringe exchange programs in the hills of Thailand’, AIDS Care, 7, pp. 489-99.
20. HAGEN, H., MCGOUGH, J.P., HANSEN, G.R., Yu, T., FIELDS, J. and RUSSELL, ALEXANDER E. (1996) ‘Incidence of blood-borne viruses in a cohort of Seattle IDUs’, paper presented at the Seventh International Conference on the Reduction of Drug Related Harm, Hobart, Australia.
21. HELPERN, M. (1934) ‘Epidemic of fatal estivo-autumnal malaria’, American Journal of Surgery, XXVI, 1, pp. 111-23.
22. HOLMAN, C.D.J., ARMSTRONG, B.K., ARIAS, L.N.et al. (1990) The Quantification of Drug Caused Morbidity and Mortality in Australia, 1988, parts 1 and 2, Canberra: Commonwealth Department of Community Services and Health.
23. LEEN, C.L.S., DAVIDSON, S.M., FLEGG, P.J. and MADAL, B.K. (1989) ‘Seven years experience of acute hepatitis B in a regional department of infectious diseases and tropical medicine’, Journal of Infection, 18, pp. 257-63.
24. MADDUX, J.F. and DESMOND, D.P. (1981) Careers of Opioid Users, New York: Praeger.
25. MAKOWER, R.M., PENNYCOOK, A.G. and MOULTON, C. (1992) ‘Intravenous drug abusers attending an inner city accident and emergency department’, Archives of Emergency Medicine, 9, pp. 32-9.
26. MANN, J., TARANTOLA, J. and NETTER, T. (1992) AIDS in the World, Cambridge, Mass.: Harvard University.
27. MIRIM, S.M., MEYER, R.E., MENDLESON, J. and ELLINGBOE, J. (1980) ‘Opiate use and sexual dysfunction’, American Journal of Psychiatry, 137, pp. 909-15.
28. MUTCHNICK, M.G., LEE, H.H. and PELEMAN, R.R. (1991) ‘Liver disease associated with intravenous drug abuse’, in LEVINE, D.P. and SOBEL, J.D. (Eds) Infections in Intravenous Drug Abusers, Oxford: Oxford University Press.
29. NURCO, D.N. and LERNER, M. (1971) The feasibility of locating addicts in the community’, International Journal of the Addictions, 6, pp. 51-62.
30. O’DONNELL, J.A. (1969) Narcotic Addicts in Kentucky, US Government Printing Office.
31. PEARSON, G. and GILMAN, M. (1994) ‘Local and regional variations in drug misuse: The British heroin epidemic of the 1980s’, in STRANG, J. and GOSSOP M. (Eds) Heroin Addiction and Drug Policy: The British System, Oxford: Oxford University Press.
32. PERLMAN, D.C., SALOMON, N., PERKINS, M.P., YANCOVITZ, S., PAONE, D. and DES JARLAIS, D.C. (1995) ‘Tuberculosis in drug users’, Clinical Infectious Diseases, 21, pp. 1253-64.
33. PERUCCI, C.A., DAVOLI, M., RAPITI, E., ABENI, D.D. and FORASTIERI, F. (1991) ‘Mortality of intravenous drug users in Rome: A cohort study’, American Journal of Public Health, 81, pp. 1307-10.
34. PRESCOR, M.J. (1943) ‘Follow-up study of treated narcotic addicts’, Public Health Report, Supplement No. 170.
35. RHODES, T. and STIMSON, G.V. (1994) ‘What is the relationship between drug taking and sexual risk, social relations and social research’, Sociology of Health and Illness, 16, 2, pp. 209-29.
36. RHODES, T., HUNTER, G.M., STIMSON, G.V., DONOGHOE, M.C., NOBLE, A., PARRY J. and CHALMERS, C. (1996) ‘Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: Injecting careers, positivity and risk behaviour’, Addiction, 91, 10, pp. 1457-67.
37. SCHEIDEGGER, C. and ZIMMERLI, W. (1989) ‘Infectious complications in drug addicts: Seven year review of 269 hospitalised narcotics abusers in Switzerland’, Reviews of Infectious Diseases, 11, pp. 486-93.
38. SELWYN, P.A. (1993) ‘Illicit drug use revisited: What a long, strange trip it’s been’, Annals of Internal Medicine, 119, 10, pp. 1044-6.
39. SKOLNICK, A. (1990) ‘Illicit drugs take another toll-death or injury from vehicle associated trauma’, Journal of the American Medical Association, 263, 23, pp. 3122-5.
40. STIMSON, G.V. and DONOGHOE, M.C. (1996) ‘Health promotion and the facilitation of individual change: The case of syringe distribution and exchange’, in RHODES, T. and HARTNOL, R. (Eds) AIDS, Drugs and Prevention: Perspectives on Individual and Community Action, London:Routledge.
41. STIMSON, G.V. and LART, R. (1991) ‘HIV, drugs and public health in England:New words, old tunes’, International Journal of the Addictions, 26, 12, pp. 1263-77.
42. STIMSON, G.V. and OPPENHEIMER, E. (1982) Heroin Addiction: Treatment and Control in Britain, London: Tavistock.
43. STRANG, J. and FARREL, M. (1992) Hepatitis B: what you always ought to have known but didn’t know to ask, London: ISDD.
44. TSUBOTA, A., CHAYAMA, K., IKEDA, K.et al. (1994) ‘Factors predictive of response to interferon alpha on therapy in hepatitis C virus infection’, Hepatology, 19, pp. 1088-94.
45. TURNER, G.C., PANTON, N. and VANDERVELDE, E.M. (1989) ‘Delta infection and drug abuse in Merseyside’, Journal of Infection, 19, pp. 113-18.
46. VAILLANT, G.E. (1973) ‘A twenty year follow-up of New York narcotic addicts’, Archives of General Psychiatry, 29, pp. 237-41.
47. VAN AMEIJDEN, E.J.C., VLAHOV, D., VAN DEN HOEK, J.A.R., FLYNN, C. and COUTINHO, R.A. (1996) ‘A comparison of pre-AIDS morbidity among injection drug users in Amsterdam and Baltimore’, paper presented at the Seventh International Conference on the Reduction of Drug Related Harm, Hobart, Australia.
48. WARD, J., MATTICK, R. and HALL, W. (1992) Key Issues in Methadone Maintenance Treatment, New South Wales: University Press.
49. WHALEN, C., HORSBURGH, C., HOM, D., LAHHART, C., SIMBERKOFF, M. and ELLNER, J. (1995) ‘Accelerated course of HIV infection after tuberculosis’, American Journal of Respiratory and Critical Care Medicine, 151, pp. 129-35.
50. WOODFIELD, D.G., HARNESS, M., RIX-TROTT, K., TSUDA, F., OKAMOTO, H. and MAYUMI, M. (1994) ‘Identification and genotyping of hepatitis C virus in injectable and oral drug users in New Zealand’, Australian and New Zealand Journal of Medicine, 24, pp. 47-50.
51. WORLD HEALTH ORGANIZATION (1992) The ICD-10 Classification of Mental and Behavioural Disorders, Geneva: World Health Organization.
52. WORLD HEALTH ORGANIZATION (1993) Death Related to Drug Abuse, Report on a WHO Consultation, Geneva, 22-5 November, Geneva: World Health Organization, Programme on Substance Abuse.
53. WORLD HEALTH ORGANIZATION INTERNATIONAL COLLABORATIVE GROUP (1994) MultiCity Study on Drug Injecting and Risk of HIV Infection, Geneva: World Health Organization.
54. ZADOR, D., SUNJIC, S. and DARKE, S. (1992) ‘Heroin related deaths in New South Wales, 1992: Toxicological findings and circumstances’, Medical Journal of Australia, 164, pp. 204-7.